Working group Experimental Endocrinology
@expendodge.bsky.social
We are experimentalists in endocrine reserach and representatives of the working group Experimental Endocriniology of the German Society of Endocrinology (DGE)
After the inspiring annual meeting of our working group in Freising with stimulating insights from all areas of experimental endocrinology, we are excited to invite you to the next meeting of our working group, taking place September 28–29, 2026, in Gießen.
Mark your calenders!
Mark your calenders!
October 28, 2025 at 7:50 AM
After the inspiring annual meeting of our working group in Freising with stimulating insights from all areas of experimental endocrinology, we are excited to invite you to the next meeting of our working group, taking place September 28–29, 2026, in Gießen.
Mark your calenders!
Mark your calenders!
Reposted by Working group Experimental Endocrinology
It was a pleasure to host Maria Meier from Konstanz presenting the NODES Delphi study working on a standardized data structure for hormonal data. You can still shape this standard and contribute by participating in the study survey! For more information see the project page: www.nodes-pne.eu
October 1, 2025 at 6:51 AM
It was a pleasure to host Maria Meier from Konstanz presenting the NODES Delphi study working on a standardized data structure for hormonal data. You can still shape this standard and contribute by participating in the study survey! For more information see the project page: www.nodes-pne.eu
👋 A heartfelt thank you from the organizers & advisory board of the AG Experimental Endocrinology (DGE)! ✨ We wish everyone safe travels home and hope the 2nd Conference on Experimental Endocrinology inspired new ideas, collaborations and energy for the future. 🚀🙌
October 1, 2025 at 4:26 AM
👋 A heartfelt thank you from the organizers & advisory board of the AG Experimental Endocrinology (DGE)! ✨ We wish everyone safe travels home and hope the 2nd Conference on Experimental Endocrinology inspired new ideas, collaborations and energy for the future. 🚀🙌
🎉Congrats to Ann-Kathrin Eiers (Tuckermann Lab, Ulm), winner of the Best Poster Award at the 2nd Conference on Experimental Endocrinology!🏆✨
Her work on glucocorticoid actions in fibroblast-like synoviocytes explores optimized anti-inflammatory therapies in rheumatoid arthritis.👏
Her work on glucocorticoid actions in fibroblast-like synoviocytes explores optimized anti-inflammatory therapies in rheumatoid arthritis.👏
October 1, 2025 at 4:06 AM
🎉Congrats to Ann-Kathrin Eiers (Tuckermann Lab, Ulm), winner of the Best Poster Award at the 2nd Conference on Experimental Endocrinology!🏆✨
Her work on glucocorticoid actions in fibroblast-like synoviocytes explores optimized anti-inflammatory therapies in rheumatoid arthritis.👏
Her work on glucocorticoid actions in fibroblast-like synoviocytes explores optimized anti-inflammatory therapies in rheumatoid arthritis.👏
🎉 Congrats to Heidi Lunze (BoneLab Dresden), winner of the Best Short Talk Prize at the 2nd Conference on Endocrinology! 🏆✨
Her mouse model with cell-type-specific expression of 11β-HSD1, sheds new light on tissue-specific glucocorticoid actions. 🧬👏
#Endocrinology #Hormones #DGEndo
Her mouse model with cell-type-specific expression of 11β-HSD1, sheds new light on tissue-specific glucocorticoid actions. 🧬👏
#Endocrinology #Hormones #DGEndo
October 1, 2025 at 3:50 AM
🎉 Congrats to Heidi Lunze (BoneLab Dresden), winner of the Best Short Talk Prize at the 2nd Conference on Endocrinology! 🏆✨
Her mouse model with cell-type-specific expression of 11β-HSD1, sheds new light on tissue-specific glucocorticoid actions. 🧬👏
#Endocrinology #Hormones #DGEndo
Her mouse model with cell-type-specific expression of 11β-HSD1, sheds new light on tissue-specific glucocorticoid actions. 🧬👏
#Endocrinology #Hormones #DGEndo
Thanks to everyone who submitted their abstracts. The quality was outstanding and the selection process was anything but easy! We’re excited to share that the final program of the 2nd Conference on Experimental Endocrinology is now ready.
✅ Registration is still open – don’t miss out!
✅ Registration is still open – don’t miss out!
September 3, 2025 at 5:06 PM
Thanks to everyone who submitted their abstracts. The quality was outstanding and the selection process was anything but easy! We’re excited to share that the final program of the 2nd Conference on Experimental Endocrinology is now ready.
✅ Registration is still open – don’t miss out!
✅ Registration is still open – don’t miss out!
Reposted by Working group Experimental Endocrinology
ICYMI: New content online: Balancing weight and muscle loss in GLP1 receptor agonist therapy
Balancing weight and muscle loss in GLP1 receptor agonist therapy
Nature Reviews Endocrinology, Published online: 28 July 2025; doi:10.1038/s41574-025-01160-6Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes. This Comment highlights emerging evidence and advocates for clinical strategies that prioritize muscle preservation to ensure the long-term success and safety of pharmacological weight management.
www.nature.com
July 30, 2025 at 5:44 PM
ICYMI: New content online: Balancing weight and muscle loss in GLP1 receptor agonist therapy
Reposted by Working group Experimental Endocrinology
A new tragedy for the Endocrine community An outstanding scientist leaves us too soon
August 4, 2025 at 6:15 PM
A new tragedy for the Endocrine community An outstanding scientist leaves us too soon
Reposted by Working group Experimental Endocrinology
ICYMI: New content online: Advances in the management of hyperglycaemia and diabetes mellitus during hospitalization
Advances in the management of hyperglycaemia and diabetes mellitus during hospitalization
Nature Reviews Endocrinology, Published online: 04 August 2025; doi:10.1038/s41574-025-01157-1Inpatient hyperglycaemia is found in the settings of known diabetes mellitus, previously undiagnosed diabetes mellitus and stress hyperglycaemia, and is associated with poor outcomes. Current approaches to managing inpatient hyperglycaemia and diabetes mellitus are outlined in this Review.
www.nature.com
August 6, 2025 at 11:31 PM
ICYMI: New content online: Advances in the management of hyperglycaemia and diabetes mellitus during hospitalization
Reposted by Working group Experimental Endocrinology
Deeply saddened to hear about the passing of an all-time-great of endocrine research, David Mangelsdorf - I just saw him at #ENDO2025, a real shock! Read his obituary here www.utsouthwestern.edu/about-us/ass... @endocrinesociety.bsky.social @esendocrinology.bsky.social @socendocrinology.bsky.social
August 7, 2025 at 11:14 AM
Deeply saddened to hear about the passing of an all-time-great of endocrine research, David Mangelsdorf - I just saw him at #ENDO2025, a real shock! Read his obituary here www.utsouthwestern.edu/about-us/ass... @endocrinesociety.bsky.social @esendocrinology.bsky.social @socendocrinology.bsky.social
7 DAYS left to submit abstracts! We invite researchers, clinicians, and students to join us for two days of exciting talks, networking, and exchange on cutting-edge topics in experimental endocrinology.
👉 Register here: www.endokrinologie.net/veranstaltun...
#DGE #ExperimentalEndocrinology #TUMunich
👉 Register here: www.endokrinologie.net/veranstaltun...
#DGE #ExperimentalEndocrinology #TUMunich
August 8, 2025 at 7:27 AM
7 DAYS left to submit abstracts! We invite researchers, clinicians, and students to join us for two days of exciting talks, networking, and exchange on cutting-edge topics in experimental endocrinology.
👉 Register here: www.endokrinologie.net/veranstaltun...
#DGE #ExperimentalEndocrinology #TUMunich
👉 Register here: www.endokrinologie.net/veranstaltun...
#DGE #ExperimentalEndocrinology #TUMunich
Reposted by Working group Experimental Endocrinology
"Six years ago, we had only one therapeutic option and now we have numerous possibilities"
Guideline chair @geraldraverot.bsky.social on the reasons for the Revised ESE Guideline on the Management of Aggressive Pituitary Tumours and Pituitary Carcinomas
View Guideline👉 doi.org/10.1093/ejen...
Guideline chair @geraldraverot.bsky.social on the reasons for the Revised ESE Guideline on the Management of Aggressive Pituitary Tumours and Pituitary Carcinomas
View Guideline👉 doi.org/10.1093/ejen...
June 16, 2025 at 1:05 PM
"Six years ago, we had only one therapeutic option and now we have numerous possibilities"
Guideline chair @geraldraverot.bsky.social on the reasons for the Revised ESE Guideline on the Management of Aggressive Pituitary Tumours and Pituitary Carcinomas
View Guideline👉 doi.org/10.1093/ejen...
Guideline chair @geraldraverot.bsky.social on the reasons for the Revised ESE Guideline on the Management of Aggressive Pituitary Tumours and Pituitary Carcinomas
View Guideline👉 doi.org/10.1093/ejen...
Reposted by Working group Experimental Endocrinology
ICYMI: New content online: Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Nature Reviews Endocrinology, Published online: 24 June 2025; doi:10.1038/s41574-025-01134-8This international Consensus Statement provides guidelines on the management of pituitary incidentalomas.
www.nature.com
June 26, 2025 at 8:04 AM
ICYMI: New content online: Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Reposted by Working group Experimental Endocrinology
📢 We are thrilled to announce that applications for the #ENSAT Scientific Awards 2025 are now open! Two awards for each category WG (#ACC, #APA, #NAPACA, #PPGL) and one for KIDS WG. Don't miss the deadline 21/07/2025.
Criteria and details available at ensat.org.
Criteria and details available at ensat.org.
ENS@T - home
ensat.org
June 26, 2025 at 10:47 AM
Reposted by Working group Experimental Endocrinology
ICYMI: New content online: Unpicking the effects of FGF21 on longevity
Unpicking the effects of FGF21 on longevity
Nature Reviews Endocrinology, Published online: 24 June 2025; doi:10.1038/s41574-025-01147-3Unpicking the effects of FGF21 on longevity
www.nature.com
June 26, 2025 at 4:31 PM
ICYMI: New content online: Unpicking the effects of FGF21 on longevity
Reposted by Working group Experimental Endocrinology
Unlock knowledge! Learn from leading experts in the field of clinical #endocrinology and #metabolism.
Join us for the 36th ESE Postgraduate Training Course in Clinical Endocrinology, Diabetes and Metabolism, online.
📅 Early Bird deadline: 5 August ⌛
Register now 👉 ow.ly/ofUA50VFMZR
Join us for the 36th ESE Postgraduate Training Course in Clinical Endocrinology, Diabetes and Metabolism, online.
📅 Early Bird deadline: 5 August ⌛
Register now 👉 ow.ly/ofUA50VFMZR
June 25, 2025 at 3:03 PM
Unlock knowledge! Learn from leading experts in the field of clinical #endocrinology and #metabolism.
Join us for the 36th ESE Postgraduate Training Course in Clinical Endocrinology, Diabetes and Metabolism, online.
📅 Early Bird deadline: 5 August ⌛
Register now 👉 ow.ly/ofUA50VFMZR
Join us for the 36th ESE Postgraduate Training Course in Clinical Endocrinology, Diabetes and Metabolism, online.
📅 Early Bird deadline: 5 August ⌛
Register now 👉 ow.ly/ofUA50VFMZR
Reposted by Working group Experimental Endocrinology
The incidence of endocrine disease is increasing, yet the workforce is not being developed and equipped to cope with the challenges this brings.
We have launched an international survey to gather your thoughts and opinions – have your say! 👇🚨https://www.research.net/r/State_of_Endocrinology2025
We have launched an international survey to gather your thoughts and opinions – have your say! 👇🚨https://www.research.net/r/State_of_Endocrinology2025
July 3, 2025 at 8:07 AM
The incidence of endocrine disease is increasing, yet the workforce is not being developed and equipped to cope with the challenges this brings.
We have launched an international survey to gather your thoughts and opinions – have your say! 👇🚨https://www.research.net/r/State_of_Endocrinology2025
We have launched an international survey to gather your thoughts and opinions – have your say! 👇🚨https://www.research.net/r/State_of_Endocrinology2025
Reposted by Working group Experimental Endocrinology
Meet Wiebke Arlt, your new ESE President!
Wiebke hopes to continue the work of her predecessors, specifically “to empower as many people as possible, from many diverse backgrounds, to participate.”
Hear about her plans as ESE President (2025-2027). 👇
youtu.be/emd9anHBPM4
@wiebkearlt.bsky.social
Wiebke hopes to continue the work of her predecessors, specifically “to empower as many people as possible, from many diverse backgrounds, to participate.”
Hear about her plans as ESE President (2025-2027). 👇
youtu.be/emd9anHBPM4
@wiebkearlt.bsky.social
Introducing Wiebke Arlt - ESE President 2025-2027
YouTube video by European Society of Endocrinology
youtu.be
July 3, 2025 at 10:26 AM
Meet Wiebke Arlt, your new ESE President!
Wiebke hopes to continue the work of her predecessors, specifically “to empower as many people as possible, from many diverse backgrounds, to participate.”
Hear about her plans as ESE President (2025-2027). 👇
youtu.be/emd9anHBPM4
@wiebkearlt.bsky.social
Wiebke hopes to continue the work of her predecessors, specifically “to empower as many people as possible, from many diverse backgrounds, to participate.”
Hear about her plans as ESE President (2025-2027). 👇
youtu.be/emd9anHBPM4
@wiebkearlt.bsky.social
Reposted by Working group Experimental Endocrinology
ESE joins with @endocrinesociety.bsky.social, the European Society for Paediatric Endocrinology and national endocrine societies, in an open letter to EU Member States outlining the endocrine community’s priorities for a future regulatory framework on #EDCs.
👉 ow.ly/thFE50WjKeM
👉 ow.ly/thFE50WjKeM
July 3, 2025 at 12:29 PM
ESE joins with @endocrinesociety.bsky.social, the European Society for Paediatric Endocrinology and national endocrine societies, in an open letter to EU Member States outlining the endocrine community’s priorities for a future regulatory framework on #EDCs.
👉 ow.ly/thFE50WjKeM
👉 ow.ly/thFE50WjKeM
Understanding endocrine systems at the molecular level is essential for progress in medicine. Join the 2nd Conference on Experimental Endocrinology to connect with peers across the spectrum—from basic science to bedside.
⏰ Sept 29–30, 2025
🌎 Freising
📌 Abstract Deadline: Aug 15th
📢 Don’t miss it!
⏰ Sept 29–30, 2025
🌎 Freising
📌 Abstract Deadline: Aug 15th
📢 Don’t miss it!
July 7, 2025 at 8:15 AM
Understanding endocrine systems at the molecular level is essential for progress in medicine. Join the 2nd Conference on Experimental Endocrinology to connect with peers across the spectrum—from basic science to bedside.
⏰ Sept 29–30, 2025
🌎 Freising
📌 Abstract Deadline: Aug 15th
📢 Don’t miss it!
⏰ Sept 29–30, 2025
🌎 Freising
📌 Abstract Deadline: Aug 15th
📢 Don’t miss it!
We are looking forward to the presentation of the German Centers for Experimental Endocrinology at the 2nd Conference on Experimental Endocrinology. Registration is open: www.endokrinologie.net/veranstaltun...
June 4, 2025 at 5:06 PM
We are looking forward to the presentation of the German Centers for Experimental Endocrinology at the 2nd Conference on Experimental Endocrinology. Registration is open: www.endokrinologie.net/veranstaltun...
Experimental Endocrinology in Germany. Here is a map of the German Centers that participitated in our survey: www.greulichlab.de/expendo. Do you feel missed, reach out to us!
June 4, 2025 at 5:03 PM
Experimental Endocrinology in Germany. Here is a map of the German Centers that participitated in our survey: www.greulichlab.de/expendo. Do you feel missed, reach out to us!
Reposted by Working group Experimental Endocrinology
New content online: Diabetes mellitus polygenic risk scores: heterogeneity and clinical translation
Diabetes mellitus polygenic risk scores: heterogeneity and clinical translation
Nature Reviews Endocrinology, Published online: 04 June 2025; doi:10.1038/s41574-025-01132-wIn this Review, the authors discuss different methods for assessing polygenic risk of diabetes mellitus and the utility of polygenic risk scores in classifying and screening for diabetes mellitus. The current limitations of these scores and ways of overcoming these limitations are also covered.
www.nature.com
June 4, 2025 at 2:43 PM
New content online: Diabetes mellitus polygenic risk scores: heterogeneity and clinical translation
Reposted by Working group Experimental Endocrinology
New content online: Endocrine-disrupting chemicals and female reproductive health: a growing concern
Endocrine-disrupting chemicals and female reproductive health: a growing concern
Nature Reviews Endocrinology, Published online: 22 May 2025; doi:10.1038/s41574-025-01131-xThis article outlines evidence pointing to an important contribution of endocrine-disrupting chemicals to increasing rates of female reproductive disorders such as abnormal puberty, impaired fertility, premature menopause or polycystic ovarian syndrome reported over the past half a century.
www.nature.com
May 22, 2025 at 3:33 PM
New content online: Endocrine-disrupting chemicals and female reproductive health: a growing concern